Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Agilux Laboratories, a contract research organisation (CRO) focused on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries, has launched GLP compliant LC/MS/MS bioanalytical services supporting nonclinical and clinical studies.
Subscribe to our email newsletter
Jim Jersey, president and CEO at Agilux, said: “In launching the LC/MS/MS GLP bioanalytical services, we have challenged ourselves to be as innovative as we were in discovery, without compromising outstanding compliance and customer service.
“At Agilux, we have challenged ourselves to innovate to the advantage of our clients. Our highly successful Discovery 2.0 has demonstrated that there was room to innovate in the discovery bioanalytical services space. In launching the LC/MS/MS GLP bioanalytical services, we have challenged ourselves to be as innovative as we were in discovery, without compromising outstanding compliance and customer service”